Trials / Completed
CompletedNCT00094484
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of cinacalcet compared with placebo in patients with stage 3 and 4 Chronic Kidney Disease (CKD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cinacalcet HCl |
Timeline
- Start date
- 2004-10-01
- First posted
- 2004-10-20
- Last updated
- 2013-05-08
Source: ClinicalTrials.gov record NCT00094484. Inclusion in this directory is not an endorsement.